Crystallography Open Database
- COD Home
- Accessing COD Data
- Add Your Data
- Documentation
Information card for entry 1518342
Preview
Coordinates | 1518342.cif |
---|---|
Original paper (by DOI) | HTML |
Chemical name | 1,4-dibenzyl-6-(3-(2-bromophenyl)-3-oxo-1-phenylpropyl)piperazine-2,3,5-trione |
---|---|
Formula | C33 H27 Br N2 O4 |
Calculated formula | C33 H27 Br N2 O4 |
SMILES | N1(C(=O)C(=O)N(C(=O)[C@@H]1[C@@H](CC(=O)c1c(Br)cccc1)c1ccccc1)Cc1ccccc1)Cc1ccccc1 |
Title of publication | Highly enantioselective access to diketopiperazines via cinchona alkaloid catalyzed Michael additions |
Authors of publication | Cabanillas, Alejandro; Davies, Christopher D.; Male, Louise; Simpkins, Nigel S. |
Journal of publication | Chem. Sci. |
Year of publication | 2015 |
Journal volume | 6 |
Journal issue | 2 |
Pages of publication | 1350 |
a | 9.7143 ± 0.0001 Å |
b | 22.5934 ± 0.0001 Å |
c | 12.6641 ± 0.0001 Å |
α | 90° |
β | 106.703 ± 0.001° |
γ | 90° |
Cell volume | 2662.23 ± 0.04 Å3 |
Cell temperature | 100.01 ± 0.1 K |
Ambient diffraction temperature | 100.01 ± 0.1 K |
Number of distinct elements | 5 |
Space group number | 4 |
Hermann-Mauguin space group symbol | P 1 21 1 |
Hall space group symbol | P 2yb |
Residual factor for all reflections | 0.0187 |
Residual factor for significantly intense reflections | 0.0185 |
Weighted residual factors for significantly intense reflections | 0.0475 |
Weighted residual factors for all reflections included in the refinement | 0.0477 |
Goodness-of-fit parameter for all reflections included in the refinement | 1.031 |
Diffraction radiation wavelength | 1.5418 Å |
Diffraction radiation type | CuKα |
Has coordinates | Yes |
Has disorder | No |
Has Fobs | No |
For the version history of this entry, please navigate to main COD server.
The link is: https://www.crystallography.net/1518342.html
All data in the COD and the database itself are dedicated to the
public domain and licensed under the
CC0
License
.
Users of the data should acknowledge the original authors of the
structural data.